Opportunity Growing For Newer Therapies In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Big pharmaceutical firms seeking to expand sales more aggressively in emerging markets should not underestimate the need for innovative therapies, specifically antiretrovirals, despite strong sales of generic medicines